193 related articles for article (PubMed ID: 36794167)
1. SARS-CoV-2 RNA-dependent RNA polymerase as a target for high-throughput drug screening.
Wu J; Chen Z; Han X; Chen Q; Wang Y; Feng T
Future Virol; 2022 Jan; ():. PubMed ID: 36794167
[TBL] [Abstract][Full Text] [Related]
2. Identifying Small-Molecule Inhibitors of SARS-CoV-2 RNA-Dependent RNA Polymerase by Establishing a Fluorometric Assay.
Bai X; Sun H; Wu S; Li Y; Wang L; Hong B
Front Immunol; 2022; 13():844749. PubMed ID: 35464436
[TBL] [Abstract][Full Text] [Related]
3. SARS-CoV-2 and SARS-CoV: Virtual screening of potential inhibitors targeting RNA-dependent RNA polymerase activity (NSP12).
Ruan Z; Liu C; Guo Y; He Z; Huang X; Jia X; Yang T
J Med Virol; 2021 Jan; 93(1):389-400. PubMed ID: 32579254
[TBL] [Abstract][Full Text] [Related]
4. Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of nsp12/7/8 RNA-dependent RNA polymerase.
Bertolin AP; Weissmann F; Zeng J; Posse V; Milligan JC; Canal B; Ulferts R; Wu M; Drury LS; Howell M; Beale R; Diffley JFX
Biochem J; 2021 Jul; 478(13):2425-2443. PubMed ID: 34198323
[TBL] [Abstract][Full Text] [Related]
5. Two conserved oligomer interfaces of NSP7 and NSP8 underpin the dynamic assembly of SARS-CoV-2 RdRP.
Biswal M; Diggs S; Xu D; Khudaverdyan N; Lu J; Fang J; Blaha G; Hai R; Song J
Nucleic Acids Res; 2021 Jun; 49(10):5956-5966. PubMed ID: 33999154
[TBL] [Abstract][Full Text] [Related]
6. Structural Basis for RNA Replication by the SARS-CoV-2 Polymerase.
Wang Q; Wu J; Wang H; Gao Y; Liu Q; Mu A; Ji W; Yan L; Zhu Y; Zhu C; Fang X; Yang X; Huang Y; Gao H; Liu F; Ge J; Sun Q; Yang X; Xu W; Liu Z; Yang H; Lou Z; Jiang B; Guddat LW; Gong P; Rao Z
Cell; 2020 Jul; 182(2):417-428.e13. PubMed ID: 32526208
[TBL] [Abstract][Full Text] [Related]
7. Screening of SARS-CoV-2 antivirals through a cell-based RNA-dependent RNA polymerase (RdRp) reporter assay.
Uppal T; Tuffo K; Khaiboullina S; Reganti S; Pandori M; Verma SC
Cell Insight; 2022 Aug; 1(4):100046. PubMed ID: 37192863
[TBL] [Abstract][Full Text] [Related]
8. A cell-based assay to discover inhibitors of SARS-CoV-2 RNA dependent RNA polymerase.
Zhao J; Guo S; Yi D; Li Q; Ma L; Zhang Y; Wang J; Li X; Guo F; Lin R; Liang C; Liu Z; Cen S
Antiviral Res; 2021 Jun; 190():105078. PubMed ID: 33894278
[TBL] [Abstract][Full Text] [Related]
9. Fast and efficient purification of SARS-CoV-2 RNA dependent RNA polymerase complex expressed in Escherichia coli.
Madru C; Tekpinar AD; Rosario S; Czernecki D; Brûlé S; Sauguet L; Delarue M
PLoS One; 2021; 16(4):e0250610. PubMed ID: 33914787
[TBL] [Abstract][Full Text] [Related]
10. Structural basis for helicase-polymerase coupling in the SARS-CoV-2 replication-transcription complex.
Chen J; Malone B; Llewellyn E; Grasso M; Shelton PMM; Olinares PDB; Maruthi K; Eng E; Vatandaslar H; Chait BT; Kapoor T; Darst SA; Campbell EA
bioRxiv; 2020 Jul; ():. PubMed ID: 32676607
[TBL] [Abstract][Full Text] [Related]
11. Facilitating SARS CoV-2 RNA-Dependent RNA polymerase (RdRp) drug discovery by the aid of HCV NS5B palm subdomain binders: In silico approaches and benchmarking.
Elghoneimy LK; Ismail MI; Boeckler FM; Azzazy HME; Ibrahim TM
Comput Biol Med; 2021 Jul; 134():104468. PubMed ID: 34015671
[TBL] [Abstract][Full Text] [Related]
12. Resolving the Dynamic Motions of SARS-CoV-2 nsp7 and nsp8 Proteins Using Structural Proteomics.
Courouble VV; Dey SK; Yadav R; Timm J; Harrison JJEK; Ruiz FX; Arnold E; Griffin PR
bioRxiv; 2021 Mar; ():. PubMed ID: 33688660
[TBL] [Abstract][Full Text] [Related]
13. A computational approach to drug repurposing against SARS-CoV-2 RNA dependent RNA polymerase (RdRp).
Ribaudo G; Ongaro A; Oselladore E; Zagotto G; Memo M; Gianoncelli A
J Biomol Struct Dyn; 2022 Feb; 40(3):1101-1108. PubMed ID: 32948103
[TBL] [Abstract][Full Text] [Related]
14. SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis.
Guo S; Lei X; Chang Y; Zhao J; Wang J; Dong X; Liu Q; Zhang Z; Wang L; Yi D; Ma L; Li Q; Zhang Y; Ding J; Liang C; Li X; Guo F; Wang J; Cen S
Signal Transduct Target Ther; 2022 Dec; 7(1):400. PubMed ID: 36575184
[TBL] [Abstract][Full Text] [Related]
15. Mutations in SARS-CoV-2 nsp7 and nsp8 proteins and their predicted impact on replication/transcription complex structure.
Reshamwala SMS; Likhite V; Degani MS; Deb SS; Noronha SB
J Med Virol; 2021 Jul; 93(7):4616-4619. PubMed ID: 33433004
[TBL] [Abstract][Full Text] [Related]
16. Revealing the Structural Plasticity of SARS-CoV-2 nsp7 and nsp8 Using Structural Proteomics.
Courouble VV; Dey SK; Yadav R; Timm J; Harrison JJEK; Ruiz FX; Arnold E; Griffin PR
J Am Soc Mass Spectrom; 2021 Jul; 32(7):1618-1630. PubMed ID: 34121407
[TBL] [Abstract][Full Text] [Related]
17. RNA-Dependent RNA Polymerase as a Target for COVID-19 Drug Discovery.
Zhu W; Chen CZ; Gorshkov K; Xu M; Lo DC; Zheng W
SLAS Discov; 2020 Dec; 25(10):1141-1151. PubMed ID: 32660307
[TBL] [Abstract][Full Text] [Related]
18. Drug repurposing screen to identify inhibitors of the RNA polymerase (nsp12) and helicase (nsp13) from SARS-CoV-2 replication and transcription complex.
Kuzikov M; Reinshagen J; Wycisk K; Corona A; Esposito F; Malune P; Manelfi C; Iaconis D; Beccari A; Tramontano E; Nowotny M; Windshügel B; Gribbon P; Zaliani A
Virus Res; 2024 May; 343():199356. PubMed ID: 38490582
[TBL] [Abstract][Full Text] [Related]
19. Global Genomic Analysis of SARS-CoV-2 RNA Dependent RNA Polymerase Evolution and Antiviral Drug Resistance.
Mari A; Roloff T; Stange M; Søgaard KK; Asllanaj E; Tauriello G; Alexander LT; Schweitzer M; Leuzinger K; Gensch A; Martinez AE; Bielicki J; Pargger H; Siegemund M; Nickel CH; Bingisser R; Osthoff M; Bassetti S; Sendi P; Battegay M; Marzolini C; Seth-Smith HMB; Schwede T; Hirsch HH; Egli A
Microorganisms; 2021 May; 9(5):. PubMed ID: 34069681
[TBL] [Abstract][Full Text] [Related]
20. Peptide inhibitors derived from the nsp7 and nsp8 cofactors of nsp12 targeting different substrate binding sites of nsp12 of the SARS-CoV-2.
Jena NR; Pant S
J Biomol Struct Dyn; 2023 Jul; ():1-13. PubMed ID: 37434315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
